Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Semapa Next
Portugal
- Lisboa
- 10/11/2022
- Unknown
- $5,500,000
Semapa Next is a venture capital firm that invests in teams of exceptional founders from Series A to late-stage funding. We support today the leaders of tomorrow. From Lisbon to Europe.
We want to be a long-term partner of exceptional teams that are positively changing the world we live in. Besides investing with patient capital, we bring a mix of entrepreneurial, operational, and financial experience to our investments.
Our team and network of advisors has direct experience in Sales & Marketing, Talent Management, Finance, and M&A with businesses across all stages of development.
We provide access to Semapa’s Group and its international network of partners to leverage opportunities of business development, technology piloting and world-class expertise in managing and growing global businesses.
- Industry Venture Capital and Private Equity Principals
- Website https://semapanext.com/
- LinkedIn https://www.linkedin.com/company/semapanext/
Related People
Ricardo PiresFounder
Portugal -
Lisbon, Lisbon,
Experienced Board Member with a demonstrated history of working in the investment management industry. Skilled in Negotiation, Business Planning, Venture Capital, Acquisitions, and Capital Markets. Strong business development professional with a Pevc focused in Private equity and venture capital from Harvard Business School.
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)